[1]
M. Al-Ahmad, J. Nurkic, A. Maher, N. Arifhodzic, and E. Jusufovic, “Tolerability of Omalizumab in Asthma as a Major Compliance Factor: 10-Year Follow Up”, Open Access Maced J Med Sci, vol. 6, no. 10, pp. 1839–1844, Oct. 2018.